Abstract:
PROBLEM TO BE SOLVED: To prepare solid preparations where a high molecular weight polymeric binder can be employed and the delayed release of an active ingredient is made possible by producing a plastic mixture of a specific polymeric binder, medicament active principle or the like under a specific condition and by molding the mixture so as to have a necessary dosage form. SOLUTION: The objective preparations are prepared by producing a plastic mixture of at least one kind selected from pharmaceutically acceptable polymeric binders having >75 K value (preferably homopolymer or a copolymer from vinylpyrrolidone) and at least one kind selected from medicament active principles, (e.g. ibuprofen or the like) and, optionally, a customary adjuvant under the condition of temperature (preferably
Abstract:
The invention relates to a method for producing solid forms of administration by means of melt extrusion. A polymer binder, at least one pharmaceutical active agent and optionally, other additives are mixed and the mixture is melted in an extruder and then extruded in the form of a continuous plastic product strand. The inventive method is characterised in that the extruder used is a planetary roller extruder (10) which preferably has one central spindle (13) and six planetary spindles (14).
Abstract:
Solid dosage forms are produced from a plastic mixture obtained by processing a polymeric binder with active agent under controlled conditions which reduce the initial K value (Fikentscher) of the binder of above 75 by less than 15. Production of solid dosage forms comprises: (a) preparing a plastic mixture from polymeric binder(s) with a K value (Fikentscher) above 75, active agent(s) and optionally conventional additives under temperature and shearing energy input conditions which reduce the molecular weight degradation of the binder by less than 15 K; and (b) forming the plastic mixture into the dosage forms.
Abstract:
The invention relates to a method for producing solid dosage forms containin g at least one physiologically compatible polymer binding agent, at least one active agent and at least one cyclodextrin as components . According to the method, the components are mixed and plasticised at a temperature below 220 .degree.C, without the addition of a solvent. The plastic mixture obtained is shaped into the dosage form. The invention also relates to the dosage forms obtained by said method.
Abstract:
The invention relates to a method for producing solid dosage forms containin g at least one physiologically compatible polymer binding agent, at least one active agent and at least one cyclodextrin as components. According to the method, the components are mixed and plasticised at a temperature below 220 ~C, without the addition of a solvent. The plastic mixture obtained is shape d into the dosage form. The invention also relates to the dosage forms obtaine d by said method.